Jordi Riba

Summary

Affiliation: Otto-von-Guericke University
Country: Germany

Publications

  1. ncbi request reprint A neurophysiological study of the detrimental effects of alprazolam on human action monitoring
    Jordi Riba
    Centre d Investigacio de Medicaments, Institut de Recerca, Servei de Farmacologia Clinica, Hospital de la Santa Creu i Sant Pau HSCSP, Departament de Farmacologia i Terapeutica, Universitat Autonoma de Barcelona, Spain
    Brain Res Cogn Brain Res 25:554-65. 2005
  2. ncbi request reprint Noradrenergic stimulation enhances human action monitoring
    Jordi Riba
    Centre d Investigacio de Medicaments, Institut de Recerca, Hospital de la Santa Creu i Sant Pau, Departament de Farmacologia i Terapeutica, Universitat Autonoma de Barcelona, 08025 Barcelona, Spain
    J Neurosci 25:4370-4. 2005
  3. ncbi request reprint Effects of the South American psychoactive beverage ayahuasca on regional brain electrical activity in humans: a functional neuroimaging study using low-resolution electromagnetic tomography
    Jordi Riba
    Area d Investigació Farmacològica, Institut de Recerca, Hospital de la Santa Creu i Sant Pau, Departament de Farmacologia i Terapeutica, Universitat Autonoma de Barcelona, Spain
    Neuropsychobiology 50:89-101. 2004
  4. pmc Naltrexone but Not Ketanserin Antagonizes the Subjective, Cardiovascular, and Neuroendocrine Effects of Salvinorin-A in Humans
    Ana Elda Maqueda
    Human Neuropsychopharmacology Group, Sant Pau Institute of Biomedical Research IIB Sant Pau, Sant Antoni Maria Claret, Barcelona, Spain Ms Maqueda and Dr Riba Centre d Investigació de Medicaments, Servei de Farmacologia Clinica, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain Dr Valle, Dr Puntes, Dr Coimbra, Ms Ballester, Ms Garrido, Ms Gonzalez, Ms Claramunt, and Dr Riba Departament de Farmacologia i Terapèutica, Universitat Autonoma de Barcelona, Barcelona, Spain Drs Valle, Antonijoan, and Riba Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM, Spain Drs Valle, Antonijoan, and Riba Pharmacokinetic and Pharmacodynamic Modelling and Simulation, IIB Sant Pau, Sant Antoni Maria Claret, Barcelona, Spain Dr Valle Medical Informatics, VA Connecticut Healthcare System, West Haven, CT Dr Addy Medical Informatics, Yale University School of Medicine, New Haven, CT Dr Addy Department of Comparative Biomedical Sciences, School of Veterinary Medicine, Louisiana State University, Japan
    Int J Neuropsychopharmacol 19:. 2016
  5. ncbi request reprint Effects of ayahuasca on sensory and sensorimotor gating in humans as measured by P50 suppression and prepulse inhibition of the startle reflex, respectively
    Jordi Riba
    Area dInvestigació Farmacològica, Institut de Recerca, Hospital de la Santa Creu i Sant Pau HSCSP, Departament de Farmacologia i Terapeutica, Universitat Autonoma de Barcelona, St Antoni Maria Claret, Spain
    Psychopharmacology (Berl) 165:18-28. 2002
  6. doi request reprint Apathy in Parkinson's disease: neurophysiological evidence of impaired incentive processing
    Saül Martínez-Horta
    Neurology Department, Movement Disorders Unit, Hospital de la Santa Creu i Sant Pau, Universitat Autonoma de Barcelona, 08025 Barcelona, Spain, Sant Pau Institute of Biomedical Research IIB Sant Pau, 08025 Barcelona, Spain, Human Neuropsychopharmacology Group, Centre d Investigacio de Medicaments, Servei de Farmacologia Clinica, Hospital de la Santa Creu i Sant Pau, 08025 Barcelona, Spain, Departament de Farmacologia i Terapeutica, Universitat Autonoma de Barcelona, Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM, Centro Investigación Biomédica en Red Enfermedades Neurodegenerativas CIBERNED, Spain, and Department of Automatic Control ESAII, Biomedical Engineering Research Center CREB, Universitat Politecnica de Catalunya, 08028 BarcelonaTech UPC, CIBER de Bioingenieria, Biomateriales y Nanomedicina CIBER BBN, Spain
    J Neurosci 34:5918-26. 2014
  7. doi request reprint Pharmacology of ayahuasca administered in two repeated doses
    Rafael G Dos Santos
    Human Experimental Neuropsychopharmacology, IIB Sant Pau, Sant Antoni Maria Claret 167, 08025 Barcelona, Spain
    Psychopharmacology (Berl) 219:1039-53. 2012
  8. ncbi request reprint Human pharmacology of ayahuasca: subjective and cardiovascular effects, monoamine metabolite excretion, and pharmacokinetics
    Jordi Riba
    Area d Investigació Farmacològica, Institut de Recerca, Hospital de la Santa Creu i Sant Pau, St Antoni Maria Claret, 167, Barcelona 08025, Spain
    J Pharmacol Exp Ther 306:73-83. 2003
  9. ncbi request reprint Daytime Ayahuasca administration modulates REM and slow-wave sleep in healthy volunteers
    Manel J Barbanoj
    Centre d Investigació del Medicament, Institut de Recerca, Servei de Farmacologia Clinica, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
    Psychopharmacology (Berl) 196:315-26. 2008
  10. doi request reprint Inhibition of alpha oscillations through serotonin-2A receptor activation underlies the visual effects of ayahuasca in humans
    Marta Valle
    Pharmacokinetic and Pharmacodynamic Modelling and Simulation, IIB Sant Pau, Sant Antoni Maria Claret, 167, 08025 Barcelona, Spain Centre d Investigació de Medicaments, Servei de Farmacologia Clinica, Hospital de la Santa Creu i Sant Pau, Sant Antoni Maria Claret, 167, 08025 Barcelona, Spain Department of Pharmacology, Therapeutics and Toxicology, Universitat Autonoma de Barcelona UAB, Barcelona, Spain Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM, Spain
    Eur Neuropsychopharmacol 26:1161-75. 2016

Collaborators

  • Marta Valle
  • Jaime Kulisevsky
  • Matthew W Johnson
  • José Alexandre S Crippa
  • José Carlos Bouso
  • Peter Anderer
  • Selma Siéssere
  • Sidarta Ribeiro
  • Marcus Heldmann
  • Miquel Angel Fullana
  • Xavier Caseras
  • Manuel Carreiras
  • S Romero
  • Joan F Alonso
  • M-J Barbanoj
  • Saül Martínez-Horta
  • Ana Elda Maqueda
  • Rafael G Dos Santos
  • Rosa Maria Antonijoan
  • Miquel Àngel Mañanas
  • Maria Rosa Ballester
  • Rafael Faria Sanches
  • Elisabet Domínguez-Clavé
  • Mireia Rabella
  • Roland R Griffiths
  • Jimena Coimbra
  • Jaime E C Hallak
  • Maite Garrido
  • Judit Claramunt
  • Ramón Fernández-Bobadilla
  • Mireia González
  • Steven Barker
  • Montserrat Puntes
  • Peter H Addy
  • Mariana López-Góngora
  • Dimitrius L Pitol
  • Javier Pagonabarraga
  • Eva Grasa
  • Débora González
  • Amanda Feilding
  • Izabela Lomnicka
  • Iluminada Corripio
  • Mario de la Fuente Revenga
  • Pablo Friedlander
  • Thomas F Münte
  • Juan Marin-Lahoz
  • Marian Waguespack
  • Flávia de Lima Osório
  • Lauro Wichert-Ana
  • Ligia R H Macedo
  • Juan C Pascual
  • Draulio Barros de Araujo
  • Matilde Elices
  • João Paulo Maia-de-Oliveira
  • Joaquim Soler
  • Enrique Alvarez
  • Rosa M Antonijoan
  • Frederic Sampedro
  • Victor Perez
  • Melina M Iyomasa
  • Antonio Escartín
  • Maria L N M Rosa
  • Priscilla H Scalize
  • Simone C H Regalo
  • Luis Querol
  • Marisa Semprini
  • Bruno F Pereira
  • Berta Pascual-Sedano
  • Ramón Fernández de Bobadilla
  • Mercedes Yritia
  • Carmen García-Sánchez
  • Rosa Homs
  • Josep F Nomdedeu
  • Gregorio Gómez-Jarabo
  • Araceli Castillo
  • Ariel Ramirez
  • Rafael de la Torre
  • Jordi Ortuño
  • Yolanda Alfaro

Detail Information

Publications28

  1. ncbi request reprint A neurophysiological study of the detrimental effects of alprazolam on human action monitoring
    Jordi Riba
    Centre d Investigacio de Medicaments, Institut de Recerca, Servei de Farmacologia Clinica, Hospital de la Santa Creu i Sant Pau HSCSP, Departament de Farmacologia i Terapeutica, Universitat Autonoma de Barcelona, Spain
    Brain Res Cogn Brain Res 25:554-65. 2005
    ..Thus, alprazolam was shown to affect brain correlates of error detection (ERN) and motor preparation (LRPs), while it did not disturb conflict monitoring on correct trials (N2) or post-error adjustments of behavior...
  2. ncbi request reprint Noradrenergic stimulation enhances human action monitoring
    Jordi Riba
    Centre d Investigacio de Medicaments, Institut de Recerca, Hospital de la Santa Creu i Sant Pau, Departament de Farmacologia i Terapeutica, Universitat Autonoma de Barcelona, 08025 Barcelona, Spain
    J Neurosci 25:4370-4. 2005
    ..The present findings suggest that the locus ceruleus-noradrenaline system exerts a rather specific effect on human action monitoring...
  3. ncbi request reprint Effects of the South American psychoactive beverage ayahuasca on regional brain electrical activity in humans: a functional neuroimaging study using low-resolution electromagnetic tomography
    Jordi Riba
    Area d Investigació Farmacològica, Institut de Recerca, Hospital de la Santa Creu i Sant Pau, Departament de Farmacologia i Terapeutica, Universitat Autonoma de Barcelona, Spain
    Neuropsychobiology 50:89-101. 2004
    ..The present results suggest the involvement of unimodal and heteromodal association cortex and limbic structures in the psychological effects elicited by ayahuasca...
  4. pmc Naltrexone but Not Ketanserin Antagonizes the Subjective, Cardiovascular, and Neuroendocrine Effects of Salvinorin-A in Humans
    Ana Elda Maqueda
    Human Neuropsychopharmacology Group, Sant Pau Institute of Biomedical Research IIB Sant Pau, Sant Antoni Maria Claret, Barcelona, Spain Ms Maqueda and Dr Riba Centre d Investigació de Medicaments, Servei de Farmacologia Clinica, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain Dr Valle, Dr Puntes, Dr Coimbra, Ms Ballester, Ms Garrido, Ms Gonzalez, Ms Claramunt, and Dr Riba Departament de Farmacologia i Terapèutica, Universitat Autonoma de Barcelona, Barcelona, Spain Drs Valle, Antonijoan, and Riba Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM, Spain Drs Valle, Antonijoan, and Riba Pharmacokinetic and Pharmacodynamic Modelling and Simulation, IIB Sant Pau, Sant Antoni Maria Claret, Barcelona, Spain Dr Valle Medical Informatics, VA Connecticut Healthcare System, West Haven, CT Dr Addy Medical Informatics, Yale University School of Medicine, New Haven, CT Dr Addy Department of Comparative Biomedical Sciences, School of Veterinary Medicine, Louisiana State University, Japan
    Int J Neuropsychopharmacol 19:. 2016
    ..Here, we assessed the involvement of kappa-opioid receptor and serotonin-2A agonism in the subjective, cardiovascular, and neuroendocrine effects of salvinorin-A in humans...
  5. ncbi request reprint Effects of ayahuasca on sensory and sensorimotor gating in humans as measured by P50 suppression and prepulse inhibition of the startle reflex, respectively
    Jordi Riba
    Area dInvestigació Farmacològica, Institut de Recerca, Hospital de la Santa Creu i Sant Pau HSCSP, Departament de Farmacologia i Terapeutica, Universitat Autonoma de Barcelona, St Antoni Maria Claret, Spain
    Psychopharmacology (Berl) 165:18-28. 2002
    ..In addition, to our knowledge P50 suppression has not been assessed previously in humans following the administration of a 5-HT(2A/2C) agonist...
  6. doi request reprint Apathy in Parkinson's disease: neurophysiological evidence of impaired incentive processing
    Saül Martínez-Horta
    Neurology Department, Movement Disorders Unit, Hospital de la Santa Creu i Sant Pau, Universitat Autonoma de Barcelona, 08025 Barcelona, Spain, Sant Pau Institute of Biomedical Research IIB Sant Pau, 08025 Barcelona, Spain, Human Neuropsychopharmacology Group, Centre d Investigacio de Medicaments, Servei de Farmacologia Clinica, Hospital de la Santa Creu i Sant Pau, 08025 Barcelona, Spain, Departament de Farmacologia i Terapeutica, Universitat Autonoma de Barcelona, Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM, Centro Investigación Biomédica en Red Enfermedades Neurodegenerativas CIBERNED, Spain, and Department of Automatic Control ESAII, Biomedical Engineering Research Center CREB, Universitat Politecnica de Catalunya, 08028 BarcelonaTech UPC, CIBER de Bioingenieria, Biomateriales y Nanomedicina CIBER BBN, Spain
    J Neurosci 34:5918-26. 2014
    ..These findings indicate impaired incentive processing and suggest a compromised mesocorticolimbic pathway in cognitively intact PD patients with apathy. ..
  7. doi request reprint Pharmacology of ayahuasca administered in two repeated doses
    Rafael G Dos Santos
    Human Experimental Neuropsychopharmacology, IIB Sant Pau, Sant Antoni Maria Claret 167, 08025 Barcelona, Spain
    Psychopharmacology (Berl) 219:1039-53. 2012
    ..It is used in ceremonial contexts for its visionary properties. The human pharmacology of ayahuasca has been well characterized following its administration in single doses...
  8. ncbi request reprint Human pharmacology of ayahuasca: subjective and cardiovascular effects, monoamine metabolite excretion, and pharmacokinetics
    Jordi Riba
    Area d Investigació Farmacològica, Institut de Recerca, Hospital de la Santa Creu i Sant Pau, St Antoni Maria Claret, 167, Barcelona 08025, Spain
    J Pharmacol Exp Ther 306:73-83. 2003
    ..MAO inhibition at this level would suffice to prevent first-pass metabolism of DMT and allow its access to systemic circulation and the central nervous system...
  9. ncbi request reprint Daytime Ayahuasca administration modulates REM and slow-wave sleep in healthy volunteers
    Manel J Barbanoj
    Centre d Investigació del Medicament, Institut de Recerca, Servei de Farmacologia Clinica, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
    Psychopharmacology (Berl) 196:315-26. 2008
    ..Given the role played by serotonin in the regulation of the sleep/wake cycle, we investigated the effects of daytime ayahuasca consumption in sleep parameters...
  10. doi request reprint Inhibition of alpha oscillations through serotonin-2A receptor activation underlies the visual effects of ayahuasca in humans
    Marta Valle
    Pharmacokinetic and Pharmacodynamic Modelling and Simulation, IIB Sant Pau, Sant Antoni Maria Claret, 167, 08025 Barcelona, Spain Centre d Investigació de Medicaments, Servei de Farmacologia Clinica, Hospital de la Santa Creu i Sant Pau, Sant Antoni Maria Claret, 167, 08025 Barcelona, Spain Department of Pharmacology, Therapeutics and Toxicology, Universitat Autonoma de Barcelona UAB, Barcelona, Spain Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM, Spain
    Eur Neuropsychopharmacol 26:1161-75. 2016
    ..These findings suggest that despite the chemical complexity of ayahuasca, 5-HT2A activation plays a key role in the neurophysiological and visual effects of ayahuasca in humans. ..
  11. ncbi request reprint Bringing ayahuasca to the clinical research laboratory
    Jordi Riba
    Centre d Investigacio de Medicaments, Institut de Recerca, Servei de Farmacologia Clinica, Hospital de la Santa Creu i Sant Pau, St Antoni Maria Claret 167, Barcelona 08025, Spain
    J Psychoactive Drugs 37:219-30. 2005
    ..It also describes the research currently underway in our laboratory, and briefly comments on two new studies we plan to undertake in order to further our knowledge of the pharmacology of ayahuasca...
  12. ncbi request reprint Increased frontal and paralimbic activation following ayahuasca, the pan-Amazonian inebriant
    Jordi Riba
    Centre d Investigacio de Medicaments, Institut de Recerca, Servei de Farmacologia Clinica, Hospital de la Santa Creu i Sant Pau, and Departament de Farmacologia i Terapéutica, Universitat Autonoma de Barcelona, Spain
    Psychopharmacology (Berl) 186:93-8. 2006
    ..Despite recent advances in the study of ayahuasca pharmacology, the neural correlates of acute ayahuasca intoxication remain largely unknown...
  13. pmc Neurophysiological evidence of impaired self-monitoring in schizotypal personality disorder and its reversal by dopaminergic antagonism
    Mireia Rabella
    Servei de Psiquiatria, Hospital de la Santa Creu i Sant Pau, C SantAntoniMaría Claret, 167, 08025 Barcelona, Spain Departament de Farmacologia i Terapèutica, Universitat Autònoma de Barcelona 167, 08025 Barcelona, Spain
    Neuroimage Clin 11:770-9. 2016
    ..We also assessed the capacity of dopaminergic antagonists to reverse these postulated deficits...
  14. ncbi request reprint Non-demented Parkinson's disease patients with apathy show decreased grey matter volume in key executive and reward-related nodes
    Saül Martínez-Horta
    Department of Neurology, Movement Disorders Unit, Hospital de la Santa Creu i Sant Pau Sant Antoni M Claret 167, Universitat Autonoma de Barcelona, 08025, Barcelona, Spain
    Brain Imaging Behav . 2016
    ..The correlations observed between apathy and cognition suggests apathy as a marker of more widespread brain degeneration even in a sample of non-demented PD patients...
  15. doi request reprint Antidepressant Effects of a Single Dose of Ayahuasca in Patients With Recurrent Depression: A SPECT Study
    Rafael Faria Sanches
    From the Department of Neurosciences and Behavior, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, Brazil Centre d Investigació de Medicaments, Servei de Farmacologia Clinica, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain National Institute of Science and Technology, Translational Medicine, Ribeirão Preto Department of Clinical Medicine, Onofre Lopes University Hospital, Brain Institute, Federal University of Rio Grande do Norte, Natal, Brazil Human Experimental Neuropsychopharmacology, Institut de Recerca, Hospital de la Santa Creu i Sant Pau Departament de Farmacologia i Terapèutica, Universitat Autònoma de Barcelona and Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM, Barcelona, Spain
    J Clin Psychopharmacol 36:77-81. 2016
    ..Our results suggest that ayahuasca may have fast-acting and sustained antidepressive properties. These results should be replicated in randomized, double-blind, placebo-controlled trials. ..
  16. pmc Neurophysiological Evidence of Compensatory Brain Mechanisms in Early-Stage Multiple Sclerosis
    Mariana López-Góngora
    Multiple Sclerosis Unit, Neurology Department, Hospital de la Santa Creu i Sant Pau, Universitat Autonoma de Barcelona, Barcelona, Spain Departament de Medicina, Universitat Autonoma de Barcelona, Barcelona, Spain Multiple Sclerosis Research Group, Biomedical Research Institute IIB Sant Pau, Barcelona, Spain
    PLoS ONE 10:e0136786. 2015
    ..Patients showed higher neuronal recruitment in tasks involving performance monitoring. Results suggest the development of compensatory brain mechanisms in early-stage MS and reflect the sensitivity of the ERN to detect these changes. ..
  17. pmc Topographic pharmaco-EEG mapping of the effects of the South American psychoactive beverage ayahuasca in healthy volunteers
    Jordi Riba
    Area d Investigació Farmacològica, Institut de Recerca, Hospital de la Santa Creu i Sant Pau HSCSP, Departament de Farmacologia i Terapeutica, Universitat Autonoma de Barcelona, Spain
    Br J Clin Pharmacol 53:613-28. 2002
    ....
  18. doi request reprint A neuroimaging study of conflict during word recognition
    Jordi Riba
    Centre d Investigació del Medicament, Institut de Recerca, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
    Neuroreport 21:741-5. 2010
    ..The effect of syllabic frequency underscores the role of sublexical processing in visual word recognition and supports the view that the initial syllable mediates between the letter and word level...
  19. ncbi request reprint Influence of individual differences in Behavioral Inhibition System on the magnitude and time course of the fear-potentiated startle
    Miquel Angel Fullana
    Departament de Psiquiatria i de Medicina Legal, Universitat Autonoma de Barcelona, Catalonia, Spain
    Int J Psychophysiol 60:323-9. 2006
    ..Our data do not support an association between this individual differences variable and the fear-potentiated startle...
  20. pmc Salvinorin-A Induces Intense Dissociative Effects, Blocking External Sensory Perception and Modulating Interoception and Sense of Body Ownership in Humans
    Ana Elda Maqueda
    Human Neuropsychopharmacology Group Sant Pau Institute of Biomedical Research IIB Sant Pau Sant Antoni María Claret, Barcelona, Spain Drs Maqueda and Riba Centre d Investigació de Medicaments, Servei de Farmacologia Clinica, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain Drs Valle, Antonijoan, Puntes, Coimbra, Ballester, Garrido, González, Claramunt, and Riba Departament de Farmacologia i Terapèutica, Universitat Autonoma de Barcelona, Spain Drs Valle, Antonijoan, and Riba Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM, Barcelona, Spain Drs Valle, Antonijoan, and Riba Pharmacokinetic and Pharmacodynamic Modelling and Simulation, IIB Sant Pau Sant Antoni María Claret, 167, 08025 Barcelona, Spain Dr Valle Medical Informatics, VA Connecticut Healthcare System, West Haven, CT Dr Addy Medical Informatics, Yale University School of Medicine, New Haven, CT Dr Addy Department of Comparative Biomedical Sciences, School of Veterinary Medicine, Louisiana State University, Skip Bertman Drive at River Road, Pittsburgh
    Int J Neuropsychopharmacol 18:. 2015
    ..Here we comprehensively studied the profiles of subjective effects of increasing doses of salvinorin-A in healthy volunteers, with a special emphasis on interoception...
  21. doi request reprint Ayahuasca Alters Structural Parameters of the Rat Aorta
    Dimitrius L Pitol
    Department of Morphology, Physiology and Basic Pathology, University of Sao Paulo, Ribeirao Preto, Brazil Department of Neuroscience and Behavior, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, Brazil Department of Biophysiologic Sciences, Faculty of Medicine of Catanduva, Catanduva, Brazil National Institute for Translational Medicine INCT TM, CNPq, Ribeirao Preto, Brazil Molecular and Cellular Biology Unit, Biosciences Institute Molecular and Cellular Biology UNESP, Rio Claro, Brazil Centre d Investigació de Medicaments, Servei de Farmacologia Clinica, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain Human Experimental Neuropsychopharmacology, Institut de Recerca, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain Departament de Farmacologia i Terapèutica, Universitat Autonoma de Barcelona, Spain and Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM, Barcelona, Spain
    J Cardiovasc Pharmacol 66:58-62. 2015
    ..Chronic treatment with the higher dose significantly increased media thickness and the ratio of media thickness to lumen diameter. More research is needed on the cardiovascular function of long-term ayahuasca consumers...
  22. doi request reprint Long-term use of psychedelic drugs is associated with differences in brain structure and personality in humans
    José Carlos Bouso
    Human Neuropsychopharmacology Group, Sant Pau Institute of Biomedical Research IIB Sant Pau, C Sant Antoni Maria Claret, 167, 08025 Barcelona, Spain International Center for Ethnobotanical Education, Research and Service, Barcelona, Spain
    Eur Neuropsychopharmacol 25:483-92. 2015
    ..These changes could underlie the previously reported personality changes in long-term users and highlight the involvement of the PCC in the effects of psychedelics. ..
  23. doi request reprint Metabolism and disposition of N,N-dimethyltryptamine and harmala alkaloids after oral administration of ayahuasca
    Jordi Riba
    Human Experimental Neuropsychopharmacology, Institute for Biomedical Research IIB Sant Pau, Barcelona, Spain
    Drug Test Anal 4:610-6. 2012
    ..Also that O-demethylation plus conjugation is an important but probably not the only metabolic route for the harmala alkaloids in humans...
  24. ncbi request reprint Determination of N,N-dimethyltryptamine and beta-carboline alkaloids in human plasma following oral administration of Ayahuasca
    Mercedes Yritia
    Area d Investigació Farmacològica, Institut de Recerca, Hospital de la Santa Creu i Sant Pau, Departament de Farmacologia i Terapeutica, Universitat Autonoma de Barcelona, St Antoni Maria Claret, 167, Barcelona 08025, Spain
    J Chromatogr B Analyt Technol Biomed Life Sci 779:271-81. 2002
    ....
  25. doi request reprint Ayahuasca: Pharmacology, neuroscience and therapeutic potential
    Elisabet Domínguez-Clavé
    Department of Psychiatry, Hospital de la Santa Creu i Sant Pau, Sant Antoni Maria Claret, 167, 08025 Barcelona, Spain Department of Psychiatry and Forensic Medicine, School of Medicine, Universitat Autonoma de Barcelona, 08193 Bellaterra Cerdanyola del Valles, Spain Electronic address
    Brain Res Bull 126:89-101. 2016
    ..More research is needed to assess the full potential of ayahuasca in the treatment of these disorders...
  26. ncbi request reprint Connectivity analysis of EEG under drug therapy
    Joan F Alonso
    Biomedical Engineering Research Centre, Automatic Control Department, Technical University of Catalonia UPC, Barcelona, Spain
    Conf Proc IEEE Eng Med Biol Soc 2007:6188-91. 2007
    ..However, nonlinear variables correlated better with the expected within-doses and within-time effects...
  27. ncbi request reprint Pattern of use and subjective effects of Salvia divinorum among recreational users
    Débora González
    Cátedra de la Fundación Cultural Fórum Filatélico de Psicobiología y Discapacidad, Departamento de Psicología Biológica y de la Salud, Facultad de Psicologia, Universidad Autonoma de Madrid, Madrid, Spain
    Drug Alcohol Depend 85:157-62. 2006
    ..Originally a shamanic inebriant used by the Mexican Mazatec Indians, the plant and its preparations are becoming increasingly popular among non-traditional users...
  28. pmc Dopamine agonist increases risk taking but blunts reward-related brain activity
    Jordi Riba
    Department of Neuropsychology, University of Magdeburg, Magdeburg, Germany
    PLoS ONE 3:e2479. 2008
    ....